Research ReportCRS ReportVersion 6
R46679
The Role of Patents and Regulatory Exclusivities in Drug Pricing
Published Jan 30, 2024Updated Jun 21, 2025
Full report
What this is
The Congressional Research Service is a nonpartisan policy and legal analysis arm of the Library of Congress. CRS reports are written for members of Congress and their staff, not the public — but they’re made available openly through Congress.gov.
- S 1128118th Congress
Ensuring Access to Generic Medications Act
Mar 30, 2023 · Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- HR 1249112th Congress
Leahy-Smith America Invents Act
Sep 16, 2011 · Became Public Law No: 112-29.
- HR 133116th Congress
Consolidated Appropriations Act, 2021
Dec 27, 2020 · Became Public Law No: 116-260.
- HR 523897th Congress
Orphan Drug Act
Jan 4, 1983 · Became Public Law No: 97-414.